PLUS THERAPEUTICS, INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 33 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $1M | ↓-3.2% | — | — | — |
| 2025-09-30 | $1M | ↓-4.1% | $-4M | ↓-53.9% | -320.8% |
| 2025-06-30 | $1M | ↑+8.7% | $5M | ↑+275.2% | -110.6% |
| 2025-03-31 | $1M | ↓-36.9% | $-17M | ↓-433.6% | -333.9% |
| 2024-12-31 | $1M | ↓-51.1% | — | — | — |
| 2024-09-30 | $1M | — | $-3M | ↑+10.7% | -260.9% |
| 2024-06-30 | $1M | — | $-3M | ↓-98.4% | -289.1% |
| 2024-03-31 | $2M | — | $-3M | ↑+32.1% | -196.7% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$1M
↓-3.2% -$45K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 63 quarters
margin trajectory tells the operating-leverage storyGross Margin↑+31.1pts
26.8%
Operating Margin↓-59.9pts
-320.8%
Net Margin↓-119.2pts
-316.6%
Go deeper
PSTV Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPSTV Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics